Timely production of A/Fujian-like influenza vaccine matching the 2003-2004 epidemic strain may have been possible using Madin-Darby canine kidney cells

Vaccine

Volumn 26, Issue 52, 2008, Pages 6852-6858

  Makizumi, Keiichi ^a   Kimachi, Kazuhiko ^a   Fukada, Katsuhiko ^a   Nishimura, Tomohiro ^a   Kudo, Yasuhiro ^a   Goto, Shuro ^a   Odagiri, Takato ^b   Tashiro, Masato ^b   Kino, Yoichiro ^a  

^a Chemo Sero Therapeutic Research Institute   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Influenza; MDCK; Vaccine

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EPIDEMIC; FEMALE; INFLUENZA; INFLUENZA VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VACCINE PRODUCTION; VIRUS ISOLATION; VIRUS STRAIN;

ANIMALS; CATTLE; CELL LINE; CHICKENS; DISEASE OUTBREAKS; EGGS; HEMAGGLUTINATION TESTS; HEMAGGLUTININS; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; VIRUS REPLICATION;

EID: 56849125782     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.09.075     Document Type: Article

References (32)

1. Baez M., Palese P., and Kilbourne E.D. Gene composition of high-yielding influenza vaccine strains obtained by recombination. J Infect Dis 141 3 (1980) 362-365
2. W.H.O. The Wkly Epidemiol Rec(WER) 78 9 (2003) 57-64
3. W.H.O. The Wkly Epidemiol Rec(WER) 79 9 (2004) 85-92
4. Ritzwoller D., Shetterly S., Yamasaki K., France E., Gershman K., Shupe A., et al. Assessment of the effectiveness of the 2003-04 influenza vaccine among children and adults-Colorado, 2003. MMWR Morb Mortal Wkly Rep 53 31 (2004) 707-710
5. Robertson J.S. An overview of host cell selection. In: Brown F., Robertson J.S., Schild G., and Wood J.M. (Eds). Inactivated influenza vaccines prepared in cell culture (1999), KARGER 7-11
6. Gregersen J.-P. A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines. Vaccine 26 26 (2008) 3297-3304
7. Polymenidou M. Canine MDCK cell lines are refractory to infection with human and mouse prions. Vaccine 26 21 (2008) 2601-2614
8. Hughes K., Zachertowska A., Wan S., Li L., Klimaszewski D., Euloth M., et al. Yield in increases in intact influenza vaccine virus from chicken allantoic fluid through isolation from insoluble allantoic debris. Vaccine 25 22 (2007) 4456-4463
9. Horimoto T., and Kawaoka Y. Direct reverse transcriptase PCR to determine virulence potential of influenza A viruses in birds. J Clin Microbiol 33 3 (1995) 748-751
10. Obata H., Tanaka T., Fujii T., Sasho C., Yamaguchi Y., and Suzuki K. Dye terminator re-cycle-sequencing method: phage plaque direct sequencing. Anal Biochem 297 1 (2001) 102-105
11. Auewarakul P., Kositanont U., Sornsathapornkul P., Tothong P., Kanyok R., and Thongcharoen P. Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine 25 4 (2007) 659-663
12. Savitsky D., and Calame K. B-1 B lymphocytes require Blimp-1 for immunoglobulin secretion. J Exp Med 203 10 (2006) 2305-2314
13. Wood J.M., Dunleavy, Newman R.W., Riley A.M., Robertson J.S., and Minor P.D. The influence of the host cell on standardisation of influenza vaccine potency. Dev Biol Stand 98 (1999) 183-188
14. Lu B., Zhou H., Ye D., Kemble G., and Jin H. Improvement of influenza A/Fujian/411/02(H3N2) virus Growth in embryonated chicken eggs by balancing the hemagglutinin and nerominidase activities, using reverse genetics. J Virol 79 11 (2005) 6763-6771
15. Neumann G., Watanabe T., Ito H., Watanabe S., Goto H., Gao P., et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci USA 96 16 (1999) 9345-9350
16. Ozaki H., Govotkova E.A., Li C., Xiong X., Webster R.G., and Webby R.J. Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics. J Virol 78 4 (2004) 1851-1857
17. Jin H., Zhou H., Liu H., Chan W., Adhikary L., Mahmood K., et al. Two residues in the hemaggulutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99. Virology 336 (2005) 113-119
18. Kodihalli S., Justewicz D.M., Gubareva L.V., and Webster R.G. Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus(H3) candidate vaccine ineffective. J Virol 69 8 (1995) 4888-4897
19. Romanova J., Katingger D., Ferko B., Vogluer R., Mochalova L., Bovin N., et al. Distinct host range of influenza H3N2 virus isolates in Vero and MDCK cells is determined by cell specific glycosylation pattern. Virology 307 (2003) 90-97
20. Katz J.M., Wang M., and Webster R.G. Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus. J Virol 64 4 (1990) 1808-1811
21. Rogers G.N., Paulson J.C., Daniels R.S., Skehel J.J., Wilson I.A., and Wiley D.C. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature 304 (1983) 76-78
22. Weis W., Brown J.H., Cusack S., Paulson J.C., Skehel J.J., and Wiley D.C. Structure of the influenza virus haemaggulitinin complex with its receptor, sialic acid. Nature 333 (1988) 426-431
23. Rocha E.P., Xu X., Hall H.E., Allen J.R., Regnery H.L., and Cox N.J. Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses. J Gen Virol 74 (1993) 2513-2518
24. Wiley D.C., Wilson I.A., and Shehel J.J. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 289 (1981) 366-373
25. Wilson I.A., Skehel J.J., and Wiley D.C. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289 (1981) 373-378
26. Gerhard W., Tewdell J., Frankel M.E., and Webster R. Antigenic structure of influenza virus haemagglutinin defined by hybridoma anibodies. Nature 290 (1981) 713-717
27. Robertson J.S., Bootman J., Newman R., Oxford J.S., Daniels R.S., Webster R.G., et al. Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A (H1N1) virus. Virology 160 (1987) 31-37
28. Wood J.M., Oxford J.S., Dunleavy U., Newman R.W., Major D., Robertson J.S., et al. Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule. Virology 171 (1989) 214-221
29. Katz J.M., and Webster R.G. Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs. J Infect Dis 160 2 (1989) 191-198
30. Govorkova E.A., Kodihalli S., Alymova I.V., Fanget B., and Webster R.G. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs. Dev Biol Stand 98 (1999) 39-51 discussion 73-4
31. Recommendations for the production and control of influenza vaccine (inactivated). WHO Technical Report Series, No. 927, 2005.
32. Nicolson C., Major D., Wood J.M., and Robertson J.S. Generation of influenza vaccine virus on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine 23 (2005) 2943-2952